Star Imaging and Path Lab Limited has announced its empanelment by the Indian Council of Social Science Research (ICSSR), Ministry of Education, Government of India, for providing medical diagnostic and laboratory services. The company disclosed this development on January 13, 2026, in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Empanelment Details

The ICSSR empanelment enables Star Imaging and Path Lab Limited to provide comprehensive medical services to a specific beneficiary group. The scope of services and key parameters are outlined below:

Service Coverage and Benefits

Under this empanelment, the company will cater to ICSSR's healthcare requirements by offering medical diagnostic and laboratory services. The services will be provided at Central Government Health Scheme (CGHS) approved rates, ensuring standardized and regulated pricing for the beneficiaries.

The empanelment covers three distinct beneficiary categories:

• ICSSR pensioners
• Current employees of the Council
• Dependents of both pensioners and employees

Regulatory Compliance

Star Imaging and Path Lab Limited emphasized that this disclosure was made in the ordinary course of business and does not constitute a material event impacting the company's financial position. The announcement was made primarily for regulatory compliance and transparency purposes under SEBI regulations.

The disclosure was signed by Md Shadab Khan, Company Secretary and Compliance Officer (Membership Number: A74659), and submitted to BSE Limited on January 13, 2026. The company trades on BSE under the symbol STARIMAGIN with scrip code 544482.

Star Imaging and Path Lab Limited has secured approval to provide medical services on a credit and cashless basis to Supreme Court of India officials and their families. The company announced this significant business development through a regulatory disclosure on January 7, 2026.

Service Agreement Details

The Supreme Court of India's competent authority has accepted the company's request to provide medical services to all serving officers and officials of the apex court. The arrangement extends coverage to dependent family members of these officials, operating under Central Government Health Scheme (CGHS) norms and guidelines.

Business Impact and Compliance

The company has clarified that this arrangement falls within the ordinary course of business operations and does not constitute a material financial impact on its operations. The deal does not qualify as a related party transaction under applicable regulations.

The medical services arrangement will be governed by multiple frameworks including applicable laws, CGHS guidelines, and Star Imaging and Path Lab's internal policies. This multi-layered governance structure ensures compliance with regulatory requirements while maintaining service quality standards.

Regulatory Disclosure

The announcement was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Md Shadab Khan signed the disclosure, ensuring proper regulatory compliance for this business development.

This contract represents an expansion of Star Imaging and Path Lab's healthcare service portfolio, bringing the company into direct service provision for one of India's most prestigious institutions. The arrangement demonstrates the company's capability to handle large-scale institutional healthcare requirements while maintaining compliance with government healthcare schemes.